Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CellaVision AB

Market Cap 3.43B 365M 315M 290M 272M 511M 34.53B 516M 1.33B 16.91B 1.37B 1.34B 58.6B P/E Ratio 2026 *
23.6x
P/E Ratio 2027 * 19.6x
Enterprise Value 3.21B 342M 295M 271M 255M 478M 32.33B 483M 1.25B 15.83B 1.28B 1.26B 54.87B EV / Sales 2026 *
4.16x
EV / Sales 2027 * 3.66x
Free-Float
83.08%
Yield 2026 *
1.92%
Yield 2027 * 2.14%
1 day-1.11%
1 week+12.70%
Current month+17.74%
1 month+15.64%
3 months-4.95%
6 months-5.71%
Current year-9.67%
1 week 125.2
Extreme 125.2
154.4
1 month 118.4
Extreme 118.4
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
194
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 53.25
Extreme 53.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 04/06/2026
Director of Finance/CFO 46 01/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 03/05/2018
Chairman 64 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-11Buy 760 0.0032%
06-08Buy

Director

314 0.0013%
06-08Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%+12.70%-24.55%-20.67% 365M
-0.39%-2.54%+9.98%-23.89% 16.56B
-2.81%+3.44%+26.52%+55.83% 1.64B
+0.88%-0.52%-28.70%+21.90% 1.11B
-3.09%+1.29%-51.68%-83.88% 963M
0.00%+0.56%-21.45%-54.20% 644M
-1.20%-1.86%-43.22%-58.05% 558M
+0.57%-1.13%+26.96%-54.23% 443M
+2.72%+1.10%-53.56%-61.21% 387M
+1.44%+3.32%+32.59% - 345M
Average -0.30%+1.50%-12.71%-30.93% 2.3B
Weighted average by Cap. -0.55%-1.10%+3.60%-21.30%

Financials

2026 *2027 *
Net sales 772M 82.29M 70.91M 65.3M 61.31M 115M 7.78B 116M 301M 3.81B 309M 302M 13.2B 862M 91.97M 79.26M 72.98M 68.53M 129M 8.7B 130M 336M 4.26B 345M 338M 14.76B
Net income 145M 15.46M 13.32M 12.27M 11.52M 21.62M 1.46B 21.85M 56.46M 716M 58M 56.77M 2.48B 174M 18.57M 16M 14.74M 13.84M 25.98M 1.76B 26.25M 67.84M 860M 69.69M 68.21M 2.98B
Net Debt -218M -23.27M -20.05M -18.47M -17.34M -32.55M -2.2B -32.9M -85.01M -1.08B -87.33M -85.48M -3.73B -266M -28.36M -24.44M -22.5M -21.13M -39.67M -2.68B -40.09M -104M -1.31B -106M -104M -4.55B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
17/06/26 142.00 kr -1.11% 24,406
16/06/26 143.60 kr -2.18% 138,201
15/06/26 146.80 kr +6.22% 297,418
12/06/26 138.20 kr +5.18% 61,122
11/06/26 131.40 kr +4.29% 60,254
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
143.60SEK
Average target price
179.00SEK
Spread / Average Target
+24.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!